Uncoupling protein gene UCP1-3826A/G, UCP2 Ins/Del and UCP3-55C/T polymorphisms in obese Turkish children

Hasibe Verdi1, Sibel Tulgar Kınık1, H Pınar Baysan-Çebi1

  • 1Departments of Medical Biology, Başkent University Faculty of Medicine, Ankara.

Insights

Genetic variations in mitochondrial uncoupling proteins (UCP1, UCP2, UCP3) are not linked to childhood obesity in Turkish children. However, UCP2 gene variations may affect early insulin response after glucose intake.

Area of Science:

  • Genetics
  • Metabolism
  • Pediatrics

Background:

  • Mitochondrial uncoupling proteins (UCP) 1, 2, and 3 are key regulators of energy metabolism.
  • Previous studies on UCP genotypes and obesity have yielded conflicting results.
  • Investigating UCP gene polymorphisms in relation to obesity is crucial for understanding metabolic health.

Purpose of the Study:

  • To examine the association between common UCP polymorphisms (UCP1-3826A/G, UCP2 Ins/Del, UCP3-55C/T) and obesity in Turkish children.
  • To analyze the relationship of these UCP polymorphisms with metabolic parameters in obese children.

Main Methods:

  • Genotyping of UCP1, UCP2, and UCP3 gene polymorphisms in 189 children (102 obese, 87 controls).
  • Measurement of fasting lipid, glucose, and insulin levels in obese children.
  • Oral glucose tolerance test (OGTT) with glucose and insulin level monitoring in 60 obese children.

Main Results:

  • No significant differences in UCP polymorphism frequencies between obese and non-obese children.
  • UCP1, UCP2, and UCP3 genotypes did not correlate with fasting metabolic parameters.
  • UCP2 Insertion allele carriers showed significantly higher 30-minute insulin levels during OGTT.

Conclusions:

  • UCP1-3826A/G, UCP2 Ins/Del, and UCP3-55C/T polymorphisms are not associated with obesity in Turkish children.
  • The UCP2 Insertion allele may negatively impact early insulin response to glucose loading.
  • Further research is needed to clarify the role of UCP2 in glucose metabolism and insulin sensitivity.
Abstract

Related Concept Videos

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
79
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
111
Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
933
Human Genetics01:28

Human Genetics

Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
1.1K
Incomplete Dominance01:43

Incomplete Dominance

Gregor Mendel's work (1822 - 1884) was primarily focused on pea plants. Through his initial experiments, he determined that every gene in a diploid cell has two variants called alleles inherited from each parent. He suggested that amongst these two alleles, one allele is dominant in character and the other recessive. The combination of alleles determines the phenotype of a gene in an organism.
28.9K
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
530